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ABSTRACT  
Background
Effectiveness of internet-based self-management in patients with asthma has been 
shown, but its cost-effectiveness is unknown. We conducted a cost-effectiveness analy-
sis of internet-based asthma self-management compared with usual care.
Methods
Cost-effectiveness analysis alongside a randomized controlled trial, with 12 months 
follow-up. Patients were aged 18 to 50 year and had physician diagnosed asthma. 
The internet-based self-management program involved weekly on-line monitoring of 
asthma control with self-treatment advice, remote Web communications, and internet-
based information. We determined quality adjusted life years (QALYs) as measured by 
the EuroQol-5D and costs for health care use and absenteeism. We performed a detailed 
cost price analysis for the primary intervention. 
Results
QALYs improved for internet-based self-management compared with usual care with 
0.024 (-0.016 to 0.065). Costs of the internet-based intervention were $254 ($243 to 
$265) during the period of 1 year. From a societal perspective, costs were $641 (95% CI, 
$-1957 to $3240) higher in the intervention group, with a cost-utility ratio of $26700 per 
QALY. From a health care perspective, total costs were $37 (95% CI, $-874 to $950) higher 
in the intervention group, with a cost-utility ratio of $1500 per QALY. At a willingness-
to-pay of $50000 per QALY, the probability that internet-based self-management was 
cost-effective compared with usual care was 62% and 82% from a societal and health 
care perspective, respectively.
Conclusions
The results suggest that internet-based self-management in asthma is cost-effective 
compared with usual care, even more so from a health care perspective than from a 
societal perspective.
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INTRODUCTION
Asthma is a chronic, inflammatory disorder  of the airways clinically characterized by 
respiratory symptoms such as wheeze, cough, dyspnoea, chest tightness and impaired 
lung function (1, 2). Treatment for asthma is aimed at improving asthma control, i.e. 
reducing current symptoms and need for short-acting bronchodilation, improving lung 
function and preventing future exacerbations (1-3).
In the past decade, the care for asthma patients has shifted from physician-managed 
care to guided self-management. Guided self-management includes asthma education, 
self-monitoring of symptoms and/or lung function and adjustment of treatment accord-
ing to an action plan guided by a health care professional (not necessarily a physician). 
Self-management has been shown to improve asthma control and quality of life and 
reduce health care utilization and sometimes improve lung function (4). 
Besides clinical effectiveness, the implementation of new disease management strat-
egies requires an economic evaluation to determine whether the clinical benefits are 
gained at reasonable costs. Several cost evaluations have compared paper-and-pencil 
self-management plans to usual care in asthma (5-11), but only a few compared costs to 
quality of life (10-11). Most of these economic evaluations found that written self-man-
agement plans for asthma were likely to be cost-effective compared with usual physi-
cian provided care. However, the implementation of paper-and-pencil self-management 
plans is hampered by patients’ and doctors’ reluctance to use written diaries (12).
Implementation of guided self-management programs may be enhanced by the 
use of internet-based technologies, particularly in remote and underserved areas. In 
a recently conducted randomized controlled trial we have shown that internet-based 
self-management is feasible and provides better clinical outcomes compared with usual 
physician provided care with regard to asthma related quality of life, asthma control, 
symptom-free days and lung function (13). Although previous trials have also evaluated 
the clinical effects of internet-based self-management in adults (14) and children (15, 
16), so far, no economic evaluations have been conducted. We therefore carried out a 
cost-utility analysis, comparing quality of life with societal and health care costs during 
one year, to determine whether the clinical benefits gained with internet-based self-
management are attained at reasonable costs. 
METHODS
Setting and participants
Two hundred patients participated in a 12-month multicenter, non-blinded, randomized 
controlled trial.  Patients were recruited from 37 general practices (69 general practitio-
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ners) in the Leiden and The Hague area and the Outpatient Clinic of the Department of 
Pulmonology at the Leiden University Medical Center, The Netherlands over the period 
from September 2005 to September 2006 (13). We included patients with physician 
diagnosed asthma as coded according to the International Classification of Primary Care 
in the electronic medical record (17), aged 18-50 years, with a prescription of inhaled 
corticosteroids for at least three months in the previous year, access to internet at home, 
mastery of the Dutch language and without serious co-morbid conditions that interfered 
with asthma treatment. Patients on maintenance oral glucocorticosteroid treatment 
were excluded. All participants gave their written consent. The study was approved by 
the Medical Ethics Committee of the Leiden University Medical Center.
Details of the randomization and intervention have been described previously (13). 
Briefly, the 200 patients were randomly assigned to internet-based self-management as 
an adjunct to usual care (internet group: 101 patients) or to usual physician-provided 
care alone (usual care group: 99 patients). Allocation took place by computer after 
collection of the baseline data, ensuring concealment of allocation. The internet-based 
self-management program included weekly monitoring of asthma control and lung 
function, immediate treatment advice according to a computerized personal action 
plan after completing the validated Asthma Control Questionnaire on the internet 
(18), on-line education and group-based education, and remote Web communication 
with a specialized asthma nurse. After one year, asthma related quality of life (Asthma 
Quality of Life Questionnaire (19)), asthma control and lung function showed a clinically 
relevant and statistically significant improvement in the internet group compared to the 
usual care group (13).
Utilities and QALYs
Utilities express the valuation of health-related quality of life on a scale from zero 
(death) to one (perfect health). Patients described their health-related quality of life 
using the EuroQol classification system (EQ-5D) (20), from which we calculated their 
utilities over time using the British tariff (21). The area under the utility curve is known 
as quality-adjusted life years (QALY) and was used as the primary outcome measure for 
the cost-effectiveness analysis. Patients additionally valued their own health status on a 
visual analogue scale (VAS). This scale from the patient perspective is potentially more 
responsive to change than other generic quality of life instruments, but is not the best 
choice for economic evaluations from a societal perspective (22). The VAS scale was 
transformed to a utility scale using the power transformation 1 – (1-VAS/100)1.61 (23).
We obtained utility measurements at baseline, 3 and 12 months. For EQ-5D measure-
ments 6.5%, 10% and 8.5% were missing and for visual analogue measurements 7%, 
10% and 9% were missing at 0, 3 and 12 months, respectively. To correct for possibly 
selective non-response, missing measurements were replaced by 5 imputed values 
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based on switching regression (24, 25) with regression variables randomisation group, 
age, sex, asthma control at baseline and available utility measures at all time points. 
We estimated the intervention effect for each of the 5 data sets by a linear regression 
model with randomisation group as only independent variable, combining the multiple 
imputation sets using Rubin’s rules (26).
Costs
We distinguished three major cost categories: intervention costs, other health care 
costs and productivity costs (10, 11). Intervention costs consisted of materials (software 
support, electronic spirometer), personnel and patient costs (travel, time, internet and 
text messaging costs). Other health care costs included contacts (including face-to-face, 
telephonic and home contacts) with health care professionals (general practitioners, 
chest physician, other specialists, physiotherapists, psychologists, complementary care 
and other paramedical professionals), emergency room visits, hospital admissions and 
both asthma and non-asthma medication.
Patients reported their use of health care resources and the hours of absence from 
work using a quarterly cost-questionnaire. Details of the drugs used were derived from 
pharmacy records. We used standard prices for units of resource use and hours of ab-
senteeism (27, 28), which were converted to the price level of 2007 according to the 
general Dutch consumer price index (29) and converted to US dollars using the purchas-
ing power parity index (€1 = $1.131) (30). Because of the one-year time horizon, costs 
were not discounted.
Cost-questionnaires were scheduled to be handed in at 3, 6, 9 and 12 months. Of 
these quarterly questionnaires, 10%, 14%, 19% and 9% were missing, respectively. 
Pharmacy records were available for 182 patients (91%). Missing cost-questionnaire 
and pharmacy record were imputed using multiple imputation, as previously described 
under ‘Utilities and QALYs’.
Statistical analysis 
The base case cost-effectiveness analysis compared societal costs with QALYs gained 
based on the British EQ-5D over the period of one year. Because of the limited degree of 
modelling in this cost utility analysis, we carried out sensitivity analyses only on the use 
of different utility measures (British EQ-5D or Visual Analogue Scale) and on the included 
cost categories (societal or health care perspective). 
Differences and statistical uncertainty of QALYs and costs were calculated using non-
parametric bootstrap estimation with 5000 random samples (1000 from each of the 5 
imputations). Statistical uncertainty of the cost-effectiveness was analyzed using the net 
benefit approach (31). The net benefit (NB) is defined as WTP x ΔQALY – Δcosts, where 
WTP is the willingness to pay for a QALY gained. This approach reformulates the QALY 
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difference into a monetary difference. In a cost-effectiveness acceptability curve we 
graphed the probability that the internet-based self-management program was cost-
effective compared with usual care as a function of WTP and reported this probability at 
commonly cited WTP values of $50000 and $100000 per QALY (32).
Analyses were carried out with Stata 9.0 (StataCorp, College Station, TX).
RESULTS
The internet group and usual care group consisted of 101 and 99 participants, respec-
tively. Mean age of the sample was 37 years and 70% of the participants were women 
(table 1). At baseline, asthma related quality of life, asthma control and medication use 
were similar for the two randomization groups. 
Table 1. Baseline characteristics
Usual care group 
(n=99)
Internet group 
(n=101)
Women 71% 68%
Age, years 37 (18-50) 36 (19-50)
Asthma duration, years 18 (0-47) 15 (1-47)
Education level
 Low
 Middle
 High
14%
33%
53%
11%
37%
52%
Care provider
 General practitioner
 Chest physician
80%
20%
79%
21%
FEV1 (pre-bronchodilator), L 3.13 (1.56-5.23) 3.08 (1.14-5.19)
FEV1 (pre-bronchodilator), % predicted 90 (53-118) 88 (34-133)
Inhaled corticosteroid dose, μg/day 517 (0-2000) 494 (0-1000)
Inhaled long-acting β2-agonist, % of patients 60% 59%
Leukotriene modifier, % of patients 2% 3%
Clinical outcomes
 Asthma Quality of Life Questionnaire *
 Asthma Control Questionnaire †
5.79 (3.03-7.00)
1.11 (0-3.86)
5.73 (3.66-6.94)
1.12 (0.07-3.22)
Patient utilities ‡
 EQ-5D utility
 EQ-5D visual analogue scale
0.89 (-0.06-1.00)
74 (35-100)
0.91 (0.49-1.00)
73 (20-100)
Data are mean (range) unless otherwise indicated. * Range 1 (worst) – 7 (best) (19). † Range 0 (best) – 6 
(worst) (18). ‡ EQ-5D = EuroQol questionnaire, 5 dimensions (20). Parts of this table were published 
previously (13).
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Utilities and QALYs
At baseline, the utilities according to the EQ-5D were non-statistically significantly 
higher for the internet group than for the usual care group. EQ-5D utilities did not reach 
a statistical significant difference throughout the study. At 3 months and 12 months 
the difference in EQ-5D utility was 0.037 (-0.007 to 0.081) and 0.006 (-0.042 to 0.054), 
respectively, in favour of the internet group. Quality adjusted life years gained in the 
internet group were estimated to be 0.024 (-0.016 to 0.065) compared to the usual care 
group (table 2).
Similarly, visual analogue scale utilities were not statistically significantly different 
throughout the study. At 3 and 12 months the difference in visual analogue scale utility 
was 0.012 (-0.026 to 0.050) and 0.013 (-0.015 to 0.040), respectively, in favour of the 
internet group. Quality of life years gained based on the visual analogue scale were 
estimated to be 0.007 (-0.017 to 0.032) in favour of the internet group (table 2).
Table 2. Utilities at 0, 3 and 12 months and QALYs *
Variable Usual care group Internet group Difference (95% CI) P value
EQ-5D
0 months 0.89 0.91 0.026 (-0.024 to 0.076) 0.31
3 months 0.89 0.93 0.037 (-0.007 to 0.081) 0.099
12 months 0.91 0.92 0.006 (-0.042 to 0.054) 0.80
QALYs 0.90 0.92 0.024 (-0.016 to 0.065) 0.25
Visual analogue scale †
0 months 0.87 0.86 -0.013 (-0.045 to 0.019) 0.43
3 months 0.87 0.89 0.012 (-0.026 to 0.050) 0.54
12 months 0.88 0.89 0.013 (-0.015 to 0.040) 0.37
QALYs 0.88 0.88 0.007 (-0.017 to 0.032) 0.57
* Values are summary estimates of the 5 data sets obtained by multiple imputation, combined using 
Rubin’s rules. † Transformed using the power transformation 1 – (1-VAS/100)1.61 (23)
Costs
The total intervention costs were estimated at $25675, which is $254 (95% CI, $243 to 
$265) per patient (table 3). The highest cost components of the internet-based interven-
tion were software support ($7917) and the patients’ time costs ($5380 for monitoring 
time and $5106 for attending the education sessions).
The difference in other health care costs amounted to $-217 (95% CI, $-1117 to $682) per 
patient indicating (non-significant) cost savings for the internet group (table 4). Patients 
in the internet group had fewer contacts with health care providers than patients in 
the usual care group. Particularly, reductions in contacts with physiotherapists ($-120, 
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p=0.03) and contacts with general practitioners ($-69, p=0.18) resulted in cost reduc-
tions for the internet group. In contrast, costs for medication were higher in the internet 
group due to increased use of inhaled corticosteroid/long-acting β2agonist combina-
tions ($82, p=0.09) and leukotriene antagonists ($25, p=0.12). The difference in other 
health care costs was similar in size to the opposite difference in intervention costs, 
resulting in a negligible difference in health care costs of $37 (95% CI, $-874 to $950), 
slightly in favour of usual care.
Patients in the internet group reported 114 hours of absence from work compared 
to 98 hours for patients in the usual care group. The 16 hours difference in absenteeism 
was estimated to be equivalent to $604 (95% CI, $-1430 to $2637) in monetary terms. 
The difference in societal costs (i.e. health care costs plus costs due to absenteeism) was 
therefore estimated at $641 (95% CI, $-1957 to $3240) in favour of usual care. 
Cost-utility analysis
From a societal perspective, costs were in favour of usual care and QALYs, based on the 
EQ-5D, were in favour of internet-based self-management. According to this base case 
analysis, the cost-utility ratio was $26700 per QALY. Due to statistical uncertainty of both 
costs and QALYs, the probability that internet-based self-management is cost-effective 
compared with usual care depends on the willingness-to-pay per QALY. This probability 
was 62% at $50000 per QALY and 74% at $100000 per QALY (figure 1). From a health care 
perspective, the lower health care costs result in a cost-utility ratio of $1500 per QALY. 
Table 3. Implementation costs ($) of internet-based self-management intervention
Component of cost Cost per unit Number of units Total cost
Materials
 software support
 electronic spirometer
7917 / yr
19.22 / device
1
101
7917
1942
Personnel
 development educational aids
 education sessions
 data review and patient communication
26 / hr
26 / hr
26 / hr
16
30
91
412
780
2351
Patient costs
 travel costs for sessions
 time costs for sessions (incl. travel time)
 time costs for monitoring * 
 internet log in costs † 
 mobile phone costs ‡
6 / session
20 / session
0.50 / log in
0.0016 / log in
0.20 / message
258
258
10873
9374
1499
1465
5106
5380
15
305
Total implementation costs 25675
Total implementation costs per patient 254
* Monitoring time was estimated at 3 minutes per log in and valued at $10 per hour, i.e. the Dutch 
standard price for unpaid labour (27). Number of units was obtained from internet log files. † Internet 
costs were valued at $23 per month. ‡ Mobile phone costs were valued at $0.20 per message.
Cost-effectiveness of internet-based self-management in asthma 97
The probability that internet-based self-management is cost-effective from a health care 
perspective was 82% at $50000 per QALY and 86% at $100000 per QALY (figure 1).
QALYs gained, based on the visual analogue scale, were less than those based on the 
EQ-5D. In this case cost-utility ratios were $91600 per QALY and $5300 per QALY from a 
societal and health care perspective, respectively.
DISCUSSION
In this study we evaluated the cost-effectiveness of a new disease management strategy, 
internet-based self-management, for patients with asthma. The internet group non-sta-
tistically significantly gained 0.024 QALY during a follow-up period of 1 year compared 
with usual care. Costs were $641 higher from a societal perspective, with an estimated 
Table 4. Average health care costs and societal costs per patient ($)
Usual care group Internet group Difference
Volume Costs Volume Costs Costs P Value
Intervention costs - - 1 254 254 <0.001
Other health care costs 
General practitioner
Chest physician 
Other specialist 
Physiotherapist 
Psychologist
Complementary care 
Other paramed. professionals
Emergency room
Day admissions
Hospitalizations
Drugs *
 Short-acting β2-agonists
 Inhaled corticosteroids (ICS)
 Long-acting β2-agonists (LABA)
 Combination ICS + LABA
 Leukotriene antagonists
 Oral corticosteroids
 Non-asthma medication
12.2
0.9
2.5
8.6
1.1
1.4
1.5
0.3
0.3
1.5
54%
50%
10%
55%
8%
12%
99%
294
63
167
234
161
87
43
45
92
589
28
89
26
264
21
2
312
10.0
0.6
2.3
4.2
1.2
1.2
0.8
0.2
0.3
1.4
50%
52%
11%
71%
23%
13%
97%
225
42
155
114
180
75
24
35
86
571
20
77
20
345
46
2
285
-69
-21
-12
-120
18
-12
-19
-10
-6
-17
-8
-12
-6
82
25
-1
-27
0.18
0.20
0.75
0.03
0.78
0.66
0.28
0.47
0.88
0.95
0.26
0.47
0.67
0.09
0.12
0.50
0.71
Subtotal other health care costs 2518 2300 -217 0.63
Total health care costs 2518 2555 37 0.94
Productivity costs † 98 hr 3131 114 hr 3735 604 0.56
Total societal costs 5647 6289 641 0.63
* Volumes of drugs represent percentage of patients. † Volumes of productivity costs are number of hours 
of absence from work
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cost-utility ratio of $26700 per QALY, which is generally considered acceptable. Both the 
estimation of QALYs gained and the calculated expenses showed considerable uncer-
tainty, which is displayed by the probability curves. At a commonly cited willingness-to-
pay threshold of $50000 per QALY (32) the internet-based self-management intervention 
had a probability of 62% and 82% to be cost-effective compared with usual care from a 
societal perspective and health care perspective, respectively. 
We have previously shown substantial and statistically significant clinical effects 
in favour of internet-based self-management with regard to asthma related quality of 
life, asthma control and lung function (13). Although the utility outcomes presented 
in the current study point in the same direction (i.e. in favor of internet-based self-
management) as the clinical outcomes, their statistical significance is less evident. 
There are two main reasons that may explain this finding. First, generic quality of life 
measures, such as the EQ-5D, must be distinguished from disease-specific quality of life 
measures, such as the Asthma Quality of Life Questionnaire (19). The latter is well known 
to be responsive to change (22). However, generic preference-based instruments may 
differentiate between the highest en lowest levels of asthma control, but are less able 
to discriminate between moderate levels (33, 34). The baseline asthma control scores 
found in our primary care study population can be classified as moderately or partly 
controlled asthma and substantial improvements in disease-specific quality of life may 
have been missed by the generic instruments. Second, the absence of a statistically sig-
nificant difference in our primary utility measure may reflect a lack of statistical power, 
since our trial was powered to detect a statistical difference in the primary outcome 
Figure 1. Cost-effectiveness acceptability curves, i.e. the probability that internet-based self-management 
is cost-effective compared with usual care depending on the willingness-to-pay per QALY from a societal 
perspective and health care perspective.
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measure, asthma related quality of life, and not explicitly to detect differences in generic 
preference-based utility measures (13, 35). 
The intervention costs of $254 per patient were similar to intervention costs of a 
paper-and-pencil asthma self-management program (10), but were half of the costs of 
intensive nurse-led telemonitoring in asthma reported by others (11). The costs of the 
technological innovation (software support, electronic spirometer, internet and mobile 
phone costs) were only about 40% of the total intervention costs. The fixed technologi-
cal costs of software support constituted about one third of the intervention costs, so 
a considerable increase in the number of users could reduce the cost per user by one 
third. Moreover, the calculations were based on costs during the one-year randomized 
controlled trial. Asthma self-management cost-effectiveness studies with a longer time 
horizon have shown that intervention costs decrease after the first year (10, 36). In our 
study, costs for education sessions only apply to the first year, thus reducing costs in 
later years by about a quarter.
The other health care costs show a reduction of contacts with health care providers 
in the internet group. Although this reduction is consistently observed in 9 out of 10 
health care providers, only the reduction in contacts with physiotherapists were statisti-
cally significant, suggesting that patients with better asthma control are less in need 
for physiotherapy. The cost of drugs for asthma show small decreases in short-acting 
β2-agonists and inhaled corticosteroids along, but increases in combination therapy 
(inhaled corticosteroids plus long-acting β2-agonists) and leukotriene antagonists in the 
self-management group. This finding, in combination with favorable clinical outcomes 
of the internet-based self-management group, suggests that asthma medication was 
used more efficiently by those in the internet group.
Our study had several limitations. First, quality adjusted life year estimates were 
calculated from only two follow-up measurements. More measurements would possibly 
have resulted in more accurate QALY estimates, but we limited the number of follow-up 
measures in order to minimize the awareness of participating in a clinical trial among 
patients in the usual care group. Second, patients were inevitably aware of the allocated 
group, which may have influenced their utility ratings. Third, our economic evaluation 
was limited to one year. As pointed out above a longer duration would probably have 
resulted in reduced intervention cost estimates after one year. It is, however, unknown 
how EQ-5D utility scores will progress after one year. 
New cost-effective disease management strategies for asthma are required to face 
up to the global burden of asthma. Internet-based self-management is an innovative 
and effective management strategy in adults with asthma that improves clinical out-
come. The results of the current study suggest that internet-based self-management is 
cost-effective compared with usual care, even more so from a health care perspective 
than from a societal perspective.
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